Acepodia Competitors and Similar CompaniesClear all

Acepodia's competitors and similar companies include 4SC, BioLineRx, EUSA Pharma and Alphamab Oncology.
Acepodia
Acepodia
Acepodia is a biotech company developing cell therapies for cancer.
4SC
4SC
4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.
BioLineRx
BioLineRx
BioLineRx is a biopharmaceutical company focused on oncology.
EUSA Pharma
EUSA Pharma
EUSA Pharma is a biopharmaceutical company focused on oncology and rare diseases.
Alphamab Oncology
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company.
Founding Date
Founding Date
2016
Founding Date
1997
Founding Date
2003
Founding Date
2015
Founding Date
2009
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
TW HQ
San Mateo, US
Locations
Planegg, DE HQ
Locations
Modi'in-Maccabim-Re'ut, IL HQ
Locations
Hemel Hempstead, GB HQ
Locations
Suzhou Shi, CN HQ
Employees
Employees
514% increase
Employees
13
Employees
2414% decrease
Employees
965% decrease
Employees
42
Valuation ($)
Valuation ($)
N/A
Valuation ($)
74 m
Valuation ($)
38.5 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€336k (FY, 2024)
Revenue (est.)
$1.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€84k (FY, 2024)
Cost of goods
$230k (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€261k (FY, 2024)
Gross profit
$950k (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
(€8.3m) (FY, 2024)
Net income
($2m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 9.1m (almost 19 years ago)
Latest funding round
$ 60m (about 7 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 100.9m
Total funding raised
$ 54.2m
Total funding raised
$ 160m
For sources of this data, please see the company profile

View Company Profiles

4SC
HQ
Planegg, DE
Employees
13

4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.

View company
BioLineRx
HQ
Modi'in-Maccabim-Re'ut, IL
Employees
24↓ 14% decrease

BioLineRx is a biopharmaceutical company focused on oncology.

View company
EUSA Pharma
HQ
Hemel Hempstead, GB
Employees
96↓ 5% decrease

EUSA Pharma is a biopharmaceutical company focused on oncology and rare diseases.

View company
Alphamab Oncology
HQ
Suzhou Shi, CN
Employees
42

Alphamab Oncology is a clinical-stage biopharmaceutical company.

View company